Home > Financial Ratios > NATCO PHARMA
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 36.7893.14298.54-62.910.46

What is the latest EBIT Growth ratio of NATCO PHARMA ?

The latest EBIT Growth ratio of NATCO PHARMA is 36.78 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar202536.78
Mar202493.14
Mar2023298.54
Mar2022-62.91
Mar20210.46

How is EBIT Growth of NATCO PHARMA Trending?

Years EBIT Growth % Change
Mar2025 36.78
-60.51
Mar2024 93.14
-68.80
Mar2023 298.54
Positive
Mar2022 -62.91
Negative
Mar2021 0.46 -

Other Financial Ratios of NATCO PHARMA


Compare EBIT Growth ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹16,173.6 Cr 8.3% 8.4% -35% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,764.0 Cr 2% 6.1% 4.7% Stock Analytics
DIVIS LABORATORIES ₹170,489.0 Cr 0.1% -3.5% 8% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,442.0 Cr -0.3% 3.8% 15.5% Stock Analytics
CIPLA ₹123,088.0 Cr 1.1% -1.1% 2.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,162.0 Cr 2% 4.8% 4.8% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

8.3%

8.4%

-35%

SENSEX

0.9%

0.8%

7.1%


You may also like the below Video Courses